Annual Short Term Debt
$14.23 M
+$2.31 M+19.33%
December 31, 2023
Summary
- As of February 7, 2025, SEEL annual short term debt is $14.23 million, with the most recent change of +$2.31 million (+19.33%) on December 31, 2023.
- During the last 3 years, SEEL annual short term debt has risen by +$11.80 million (+485.27%).
- SEEL annual short term debt is now at all-time high.
Performance
SEEL Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$10.16 M
-$2.98 M-22.68%
June 30, 2024
Summary
- As of February 7, 2025, SEEL quarterly short term debt is $10.16 million, with the most recent change of -$2.98 million (-22.68%) on June 30, 2024.
- Over the past year, SEEL quarterly short term debt has dropped by -$5.45 million (-34.91%).
- SEEL quarterly short term debt is now -34.91% below its all-time high of $15.60 million, reached on September 30, 2023.
Performance
SEEL Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
SEEL Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.3% | -34.9% |
| 3 y3 years | +485.3% | -14.8% |
| 5 y5 years | - | - |
SEEL Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1232.2% | -34.9% | +851.0% |
| 5 y | 5-year | at high | +1232.2% | -34.9% | >+9999.0% |
| alltime | all time | at high | -100.0% | -34.9% | -100.0% |
Seelos Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $10.16 M(-22.7%) |
| Mar 2024 | - | $13.14 M(-7.7%) |
| Dec 2023 | $14.23 M(+19.3%) | $14.23 M(-8.8%) |
| Sep 2023 | - | $15.60 M(+26.0%) |
| Jun 2023 | - | $12.39 M(+6.0%) |
| Mar 2023 | - | $11.68 M(-2.0%) |
| Dec 2022 | $11.92 M(+1016.4%) | $11.92 M(+11.9%) |
| Sep 2022 | - | $10.65 M(+42.8%) |
| Jun 2022 | - | $7.46 M(+75.0%) |
| Mar 2022 | - | $4.26 M(+299.3%) |
| Dec 2021 | $1.07 M(-56.1%) | $1.07 M(+1994.1%) |
| Sep 2021 | - | $51.00 K(-7.3%) |
| Jun 2021 | - | $55.00 K(-97.7%) |
| Mar 2021 | - | $2.35 M(-3.5%) |
| Dec 2020 | $2.43 M(-63.4%) | $2.43 M(>+9900.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $6.65 M(-29.3%) | $6.65 M(-9.8%) |
| Sep 2016 | - | $7.37 M(-8.6%) |
| Jun 2016 | - | $8.07 M(-7.7%) |
| Mar 2016 | - | $8.75 M(-7.0%) |
| Dec 2015 | $9.40 M(+6044.4%) | $9.40 M(+250.4%) |
| Sep 2015 | - | $2.68 M(+191.9%) |
| Jun 2015 | - | $919.00 K(+73.1%) |
| Mar 2015 | - | $531.00 K(+247.1%) |
| Dec 2014 | $153.00 K(-94.1%) | $153.00 K(-87.3%) |
| Sep 2014 | - | $1.20 M(+1.9%) |
| Jun 2014 | - | $1.18 M(-55.6%) |
| Mar 2014 | - | $2.66 M(+2.3%) |
| Dec 2013 | $2.60 M(-35.0%) | $2.60 M(+80.4%) |
| Sep 2013 | - | $1.44 M(+2.1%) |
| Jun 2013 | - | $1.41 M(-64.7%) |
| Sep 2012 | - | $4.00 M(0.0%) |
| Jun 2012 | - | $4.00 M(0.0%) |
| Mar 2012 | - | $4.00 M(0.0%) |
| Dec 2011 | $4.00 M | $4.00 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $247.70 K(-42.7%) |
| Dec 2010 | $432.30 K(-96.4%) | $432.30 K(+1.1%) |
| Sep 2010 | - | $427.60 K(+0.2%) |
| Jun 2010 | - | $426.80 K(-95.7%) |
| Mar 2010 | - | $9.92 M(-18.3%) |
| Dec 2009 | $12.15 M(>+9900.0%) | $12.15 M(>+9900.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2008 | - | $1.00 M(0.0%) |
| Jun 2008 | - | $1.00 M(-49.2%) |
| Sep 2007 | - | $1.97 M(+1.6%) |
| Jun 2007 | - | $1.94 M(-60.5%) |
| Mar 2007 | - | $4.90 M(+0.7%) |
| Dec 2006 | $4.87 M(+48.1%) | $4.87 M(-19.1%) |
| Sep 2006 | - | $6.02 M(-0.7%) |
| Jun 2006 | - | $6.06 M(+93.7%) |
| Mar 2006 | - | $3.13 M(-4.9%) |
| Dec 2005 | $3.29 M(+410.6%) | $3.29 M(+822.6%) |
| Sep 2005 | - | $356.50 K(-23.3%) |
| Jun 2005 | - | $465.10 K(-16.9%) |
| Mar 2005 | - | $559.60 K(-13.1%) |
| Dec 2004 | $644.10 K(-28.3%) | $644.10 K(-12.2%) |
| Sep 2004 | - | $733.60 K(-9.4%) |
| Jun 2004 | - | $809.80 K(-7.0%) |
| Mar 2004 | - | $870.50 K(-3.2%) |
| Dec 2003 | $898.90 K(+47.4%) | $898.90 K(+15.1%) |
| Sep 2003 | - | $781.30 K(+22.3%) |
| Jun 2003 | - | $638.60 K(-42.1%) |
| Mar 2003 | - | $1.10 M(+80.9%) |
| Dec 2002 | $609.70 K(+112.1%) | $609.70 K(+21.5%) |
| Sep 2002 | - | $501.70 K(+23.8%) |
| Jun 2002 | - | $405.30 K(+37.6%) |
| Mar 2002 | - | $294.60 K(+2.5%) |
| Dec 2001 | $287.50 K(+187.5%) | $287.50 K(+31.2%) |
| Sep 2001 | - | $219.10 K |
| Dec 1999 | $100.00 K(-96.1%) | - |
| Dec 1997 | $2.57 M | - |
FAQ
- What is Seelos Therapeutics annual short term debt?
- What is the all time high annual short term debt for Seelos Therapeutics?
- What is Seelos Therapeutics annual short term debt year-on-year change?
- What is Seelos Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly short term debt year-on-year change?
What is Seelos Therapeutics annual short term debt?
The current annual short term debt of SEEL is $14.23 M
What is the all time high annual short term debt for Seelos Therapeutics?
Seelos Therapeutics all-time high annual short term debt is $14.23 M
What is Seelos Therapeutics annual short term debt year-on-year change?
Over the past year, SEEL annual short term debt has changed by +$2.31 M (+19.33%)
What is Seelos Therapeutics quarterly short term debt?
The current quarterly short term debt of SEEL is $10.16 M
What is the all time high quarterly short term debt for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly short term debt is $15.60 M
What is Seelos Therapeutics quarterly short term debt year-on-year change?
Over the past year, SEEL quarterly short term debt has changed by -$5.45 M (-34.91%)